FolioLanternBeta
UTHRUnited Therapeutics Corp

Louis Sullivan

Director at United Therapeutics Corp, as of Jul 23, 2026Sold $3.0M of stock in the past 12 months: 100% with no plan disclosed.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
6K
shares sold, past 12 months
1
days with sales
$3.0M
largest single day, Dec 22, 2025
5
companies filed for

Share of stake sold and shares held at United Therapeutics Corp are not shown: the holdings do not reconcile with the filings. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNovDec 2025: $3.0M no plan disclosed$3.0MDecJanFebMarAprMayJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
United Therapeutics Corp (UTHR)DirectorJun 28, 2004Jul 23, 2026
Henry Schein (HSIC)Former DirectorMar 15, 2004Apr 4, 2016
3M (MMM)Former DirectorAug 13, 2003May 11, 2006
Bristol Myers Squibb (BMY)Former DirectorOct 1, 2003Apr 4, 2006
Equifax (EFX)Former DirectorOct 2, 2003Jan 3, 2005

Also a director at

Henry Schein (HSIC) (no filing in the last 18 months), 3M (MMM) (no filing in the last 18 months), Bristol Myers Squibb (BMY) (no filing in the last 18 months), Equifax (EFX) (no filing in the last 18 months)

Recent filings

The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.